Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Videos|December 23, 2021

Upcoming Post-Conference Perspectives: ASH 2021

Author(s)Rafael Fonseca, MD

Rafael Fonseca, MD, shares his excitement for an upcoming AJMC Post-Conferences Perspectives video series covering the 2021 American Society of Hematology annual meeting.

Episodes in this series

Expert on Multiple Myeloma

EP. 1 Upcoming Post-Conference Perspectives: ASH 2021

Expert on MM

EP. 2 The MASTER Trial: Frontline Dara-KRd in Newly Diagnosed Multiple Myeloma

Expert on Multiple Myeloma

EP. 3 Frontline Use of Daratumumab-Based Regimens in Transplant-Ineligible MM

Expert on MM

EP. 4 Rescue Isatuximab in Transplant-Ineligible, Treatment Naïve NDMM

Expert on MM

EP. 5 Multiple Myeloma: Current Approaches to Frontline Therapy

Expert on MM

EP. 6 2-Year Followup Data From the GRIFFIN Trial in Transplant-Ineligible NDMM

Expert on MM

EP. 7 Novel Therapy for Multiple Myeloma: Future Directions in Care

Ajay Nooka, MD, MPH, FACP

EP. 8 How Should MRD Results Be Used? Experts Don’t Necessarily Agree, Dr Ajay Nooka Says

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Patient and caregiver | Image Credit: © manassanant -stock.adobe.com

Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma

ByMaggie L. Shaw

June 26th 2026

Prerna Mewawalla, MD

A Personal Mission: Prerna Mewawalla, MD, on Myeloma’s Transformation

ByMaggie L. Shaw,Prerna Mewawalla, MD

June 19th 2026

Paul Richardson, MD, lead investigator of SUCCESSOR-2, calls the CELMoD "CAR T in a pill" in touting its potency and convenience. | Image: Dana Farber Cancer Institute

Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma

June 14th 2026

Ajai Chari, MD, UCSF

Rewriting the Rules on Multiple Myeloma Resistance: Ajai Chari, MD

ByMaggie L. Shaw,Ajai Chari, MD

June 4th 2026

CincinnatiSkyline | Image Credit: © onbilous-stock.adobe.com

CAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer Advances

ByElla Hohmann, MS

May 26th 2026

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

National HIV Testing Day Highlights Expanding PrEP, PEP Access, Persistent Barriers

Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma

Health Equity & Access Weekly Roundup: June 26, 2026

Health Care Spending to Hit $9 Trillion by 2034, According to New Analysis